Akeso, Inc. Stock Boerse Muenchen
Stocks
4RY
KYG0146B1032
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Boerse Muenchen
16:43:30 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 10.61 EUR | -0.38% |
|
+1.19% | -13.41% |
| Market Cap | 75.11B 11.21B 9.69B 9.16B 8.3B 15.57B 1,074B 15.72B 109B 42.07B 544B 42.1B 41.17B 1,739B | P/E 2026 * |
-440x | P/E 2027 * | 84.2x |
|---|---|---|---|---|---|
| Enterprise Value | 71.38B 10.65B 9.21B 8.71B 7.89B 14.8B 1,021B 14.94B 104B 39.98B 517B 40.01B 39.12B 1,652B | EV / Sales 2026 * |
15.1x | EV / Sales 2027 * | 9.98x |
| Free-Float |
78.33% | Yield 2026 * |
-
| Yield 2027 * | 0.01% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 9926 | Delayed | |
Tradegate
| 4RY | Real-time | |
|
Deutsche Boerse AG
| 4RY | Delayed | |
|
Börse Stuttgart
| 4RY | Delayed | |
|
Boerse Muenchen
| 4RY | Real-time |
| Current month | +7.52% | ||
| 1 month | +1.53% | ||
| 3 months | +7.61% | ||
| 6 months | -13.03% | ||
| Current year | -13.74% |
| 1 week | 9.86 |  | 10.66 |
| 1 month | 9.38 | | 11.2 |
| 3 years | 3.8 | | 19.8 |
| 5 years | 1.49 | | 19.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peng Zhang
PRN | Corporate Officer/Principal | 50 | 2019-11-15 |
Zhongmin Wang
PRN | Corporate Officer/Principal | 57 | 2019-11-15 |
Baiyong Li
CTO | Chief Tech/Sci/R&D Officer | 58 | 2012-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Michelle Xia
CHM | Chairman | 59 | 2012-02-29 |
Baiyong Li
BRD | Director/Board Member | 58 | 2012-02-29 |
Zhongmin Wang
BRD | Director/Board Member | 57 | 2019-11-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.38% | +1.19% | -23.12% | +137.89% | 11.24B | |
| -1.38% | +2.23% | +48.54% | +100.96% | 70.24B | |
| -1.04% | -1.22% | +33.27% | +74.98% | 62.63B | |
| -4.29% | -5.04% | -17.82% | +349.64% | 27.36B | |
| +0.16% | +1.53% | +34.92% | +17.47% | 25.71B | |
| -2.20% | -6.81% | -0.05% | -15.04% | 24.83B | |
| +1.61% | +0.42% | +19.44% | -20.66% | 19.52B | |
| +1.26% | -9.06% | +165.21% | +308.08% | 15.51B | |
| -3.91% | -5.71% | -8.71% | +521.92% | 14.66B | |
| -5.54% | -1.16% | -8.13% | +810.99% | 14.69B | |
| Average | -1.70% | -1.33% | +24.36% | +228.62% | 30.57B | |
| Weighted average by Cap. | -1.52% | -0.64% | +29.11% | +163.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.74B 707M 611M 578M 523M 982M 67.74B 991M 6.9B 2.65B 34.31B 2.65B 2.6B 110B | 7.09B 1.06B 915M 865M 783M 1.47B 101B 1.48B 10.32B 3.97B 51.36B 3.97B 3.89B 164B |
| Net income | -205M -30.54M -26.41M -24.96M -22.61M -42.42M -2.93B -42.84M -298M -115M -1.48B -115M -112M -4.74B | 880M 131M 114M 107M 97.24M 182M 12.58B 184M 1.28B 493M 6.38B 493M 482M 20.37B |
| Net Debt | -3.73B -557M -482M -455M -412M -774M -53.38B -781M -5.43B -2.09B -27.04B -2.09B -2.05B -86.38B | -4.39B -655M -567M -536M -485M -910M -62.81B -919M -6.39B -2.46B -31.82B -2.46B -2.41B -102B |
| Date | Price | Change |
|---|---|---|
| 26-09-15 | €10.61 | -0.38% |
| 26-09-14 | €10.65 | +7.97% |
| 26-09-11 | €9.864 | -3.58% |
| 26-09-10 | €10.23 | -0.92% |
| 26-09-09 | €10.33 | -2.69% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 9926 Stock
- 4RY Stock
Select your edition
All financial news and data tailored to specific country editions
